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Acinetobacter baumannii had emerged as an important nosocomial and opportunistic
pathogen worldwide. To assess the evolution of colistin resistance in A. baumannii and
its effect on bacterial fitness, we exposed five independent colonies of A. baumannii
ATCC 17978 to increasing concentrations of colistin in agar (4/5) and liquid media
(1/5). Stable resistant isolates were analyzed using whole genome sequencing. All
strains were colistin resistant after exposure to colistin. In addition to the previously
reported lpxCAD and pmrAB mutations, we identified four novel putative colistin
resistance genes: A1S_1983, hepA, A1S_3026, and rsfS. Lipopolysaccharide (LPS)
loss mutants exhibited higher fitness costs than those of the pmrB mutant in nutrient-
rich medium. The colistin-resistant mutants had a higher inhibition ratio in the serum
growth experiment than that of the wild type strain in 100% serum. Minimum inhibitory
concentration (MIC) results showed that the LPS-deficient but not the pmrB mutant
had an altered antibiotic resistance profile. The compensatory mutations partially
or completely rescued the LPS-deficient’s fitness, suggesting that compensatory
mutations play an important role in the emergence and spread of colistin resistance
in A. baumannii.
Keywords: Acinetobacter baumannii, colistin, resistance mechanism, fitness cost, whole genome sequencing
INTRODUCTION
Acinetobacter baumannii had emerged as an important nosocomial and opportunistic pathogen
worldwide, especially in intensive care units (Peleg et al., 2008). A. baumannii treatment is difficult
because the clinical strains generally show resistance to multiple antibiotics (Peleg et al., 2008).
Because the extensively drug-resistant isolates demonstrated sensitivity only to colistin, colistin
has become the only clinically useful agent against these pathogens (Falagas et al., 2005; Giske
et al., 2008; Magiorakos et al., 2012). However, due to its low efficacy, colistin should be used in
combination antibiotic therapy for the treatment of XDR A. baumannii (Durante-Mangoni et al.,
2014).
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Colistin is a polycationic antimicrobial peptide that targets the
polyanionic bacterial lipopolysaccharide (LPS) of Gram-negative
bacteria. There are two different colistin resistance mechanisms
(Beceiro et al., 2014). The first involves the inactivation of
the lipid A biosynthesis pathway and the complete loss of
surface LPS. This loss might be caused by mutations in lpxC,
lpxA, or lpxD. Isolates harboring these mutations showed
high colistin minimum inhibitory concentrations (MICs),
although their fitness cost was also high (Beceiro et al., 2014;
Wand et al., 2015). The second resistance mechanism is
mediated by the pmrAB two-component system. Mutations in
pmrA and pmrB induce the activation of pmrC, which adds
phosphoethanolamine (PEtn) to the hepta-acylated form of lipd
A (Beceiro et al., 2011). The pmrB mutation did not result in
growth retardation (Durante-Mangoni et al., 2015; Wand et al.,
2015).
Antimicrobial pressure drives the evolution of antimicrobial
resistance in bacteria (Baker et al., 2013), and resistance is
often associated with reduced bacterial fitness. Epistasis can
compensate for the fitness cost of these mutants (Andersson
and Hughes, 2010). Epistasis occurs not only within the
same resistance pathway but also in different resistance
pathways. In fluoroquinolone resistance, the parC mutation
had the greatest effect on increase fitness of low fitness
strains that harbored mutations in gyrA and marR (Marcusson
et al., 2009). Moreover, the cost of multiple resistance
was smaller than expected during the evolution of multi-
drug resistance (Trindade et al., 2009). Understanding the
fitness cost of the evolution of resistance is important
to control the spread of resistant bacteria (Baker et al.,
2013).
To assess the evolution of A. baumannii colistin resistance, we
evolved A. baumannii through continuous exposure to colistin
in agar plates and liquid media. Four novel putative colistin
resistance genes were identified in addition to lpxCAD and
pmrAB. Fitness and resistance compensatory mutations appeared
in the bacteria exposed to colistin.
MATERIALS AND METHODS
Bacterial Isolates and Antimicrobial
Susceptibility Testing
All bacteria used in this study were the ATCC 17978 strain
and its laboratory-evolved mutants of A. baumannii. The MICs
were determined by broth dilution using Etest (AB Biodisk,
Solna, Sweden) on Mueller-Hinton (MH) agar. The results were
interpreted according to the CLSI or EUCAST breakpoints
(Clinical and Laboratory Standards Institute, 2014; European
Committee on Antimicrobial Susceptibility Testing, 2015). The
bacteria were cultured in Luria–Bertani (LB) medium at 37◦C.
Laboratory-Evolved Colistin Resistant
Mutants
Four independent single colonies of A. baumannii ATCC 17978
were grown overnight at 37◦C. The in vitro serial passage
experiments were performed using three methods. First, the
bacteria were streaked on LB agar plates containing 10 mg/L
colistin once each day for 15 days and then incubated at 37◦C.
Then, the bacteria were serially passaged for another 15 days
in the presence of 50, 100, and 200 mg/L colistin. Second, the
bacteria were streaked on LB agar plates containing 10 mg/L
colistin once each day for 60 days and then incubated at
37◦C. Third, the cultures were exposed to serially increasing
concentrations of colistin, starting from 1/2 the MIC and
doubling every day for 12 days. The overnight cultures were
stored at−80◦C prior to the experiments and analysis.
Whole Genome DNA Sequencing and
Analysis
Bacteria from a single colony were cultured overnight at
37◦C in MH broth. The genomic DNA was extracted using a
QIAamp DNA minikit (Qiagen, Valencia, CA, USA) following
the protocol of the manufacturer (Hua et al., 2012). Agarose
gel electrophoresis and a NanoDrop spectrophotometer (ND-
1000, ThermoFisher, Waltham, MA, USA) were used to
determine the quality and quantity of the extracted genomic
DNA. The 300 bp library used for Illumina paired-end
sequencing was constructed from 5 µg of genomic DNA
purified from the laboratory-evolved mutants. Mapping and
SNP detection were performed using breseq (Deatherage and
Barrick, 2014). The regions containing the detected SNPs
were amplified by PCR. The PCR products were sent to
Biosune (Biosune, Hangzhou, China) for Sanger sequencing.
Duplications were detected using the CLC genomic workbench
(8.02.2) and were verified by real-time PCR (Supplementary
Table S2).
Fitness Cost and Serum Resistance
Measurement
Four independent cultures per strain were grown overnight in
MH (Mueller–Hinton), diluted 1:1000 [MH or fetal bovine serum
(FBS)] and aliquoted into a flat-bottom 96-well plate in four
replicates. The plate was agitated at 37◦C. The OD600 of each
culture was determined every 5 min for 16 h using a the BioTEK
Synergy plate reader (Biotek, Winooski, VT, USA). The growth
rate was estimated by an R script based on the OD600 curves
(Li et al., 2015). Fitness data are shown in the Supplementary
Table S1. Statistical analyses were performed using R 3.2.1 (R
Development Core Team, 2015). Two-way analysis of variance
(ANOVA) and TukeyHSD analysis were used to assess differences
between the means, with a significant probability at a P value of
≤0.05.
RESULTS
Mutations in Laboratory-Evolved Colistin
Resistant Strains
To investigate the colistin resistance mechanism in A. baumannii,
we evolved A. baumannii ATCC 17978 in agar plates and
liquid media with increasing or constant concentrations of
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colistin. A strain description and the MICs for colistin of the
laboratory-evolved strains are listed in Supplementary Table
S1. The MIC of ATCC 17978 for colistin was 0.19 mg/L. The
MICs of the laboratory-evolved strains ranged from 6 mg/L
to > 256 mg/L. The final isolates from each colony were sent
for whole genome sequencing (WGS) to identify mutations. The
mutations in the laboratory-evolved strains were detected via
breseq, which mapped the sequence reads onto the ATCC 17978
reference genome. Then, the generation time each mutation
appeared during the experiment was determined by PCR and
sanger sequencing.
The mutations that occurred in the early stage of evolution
were found in pmrB, lpxC, lpxA, and lpxD (Figure 1).
Additional mutations were detected in A1S_1983, hepA
(A1S_2462), A1S_3026, rsfS (A1S_0570), and adeS (A1S_1754)
(Supplementary Tables S3 and S4).
Colistin Resistance had a Fitness Cost
Among the mutations detected, A1S_1983, hepA, A1S_3026,
and rsfS were hypothesized to be involved in colistin
resistance. Conversely, the adeS mutation was not
involved in colistin resistance (data not shown). The
ratio of the A1S_0570 mutation in A-4-30 (XH187)
was 36%, and this ratio increased to 100% in A-4-45
(XH190).
To investigate the effect of the mutations on A. baumannii
fitness, we measured the growth rate of the laboratory-evolved
strains as a proxy for fitness. The strains selected in the
agar plates showed a high fitness cost in the first 15 selected
generations, while increased resistance and fitness compensation
were observed later in the later selection process (Figure 2). The
evolution in colistin resistance and fitness was diverse among
the four lineages. In lineage 1, no fitness compensation was
observed while resistance to colistin was increased (Figure 2A).
In lineage 2, the fitness was partially recovered with a mutation in
A1S_3026, and the resistance to colistin increased (Figure 2B).
Due to contamination, lineage 3 did not have enough isolates
for analysis. In lineage 4, the fitness was completely recovered
with a mutation in A1S_0570, while the resistance increased
(Figure 2D). A 100 kb duplication occurred in A-4-45(XH193)
and A-4-60(XH190; Figure 3), which showed a higher fitness
compared to that of A-4-30(XH187). These results indicated that
the duplication of the long chromosome fragment may play a
role in the bacterial fitness. In addition, the growth of strains
harboring the pmrB mutation was slightly retarded (Figure 2E).
Lipopolysaccharide Affects Serum
Resistance
To investigate the effect of LPS on the serum resistance of
A. baumannii, we measured the growth rate of the wild type strain
FIGURE 1 | The evolutionary pathway of colistin resistance in Acinetobacter baumannii 17978 in solid agar and liquid medium. (A) Four colonies of
A. baumannii ATCC 17978 were inoculated in a solid agar plate containing 10 mg/L colistin and serially passaged for 15 days. Then, one colony was continuously
cultured with 10 mg/L colistin on agar plates for 45 days. Another colony was streaked on 50 mg/L colistin plates for a 15 days serial passage. Then, the bacteria
were streaked onto 100 and 200 mg/L colistin plates for 15 days. The strains were stored at −80◦C every 15 days. The final strains were sent for whole genome
sequencing. The mutations were detected by breseq, which mapped the sequenced reads onto the reference genome. The mutation sites in the final strain were
identified by PCR and Sanger sequencing. The mutations related to colistin resistance or fitness are labeled above the strain. (B) One lineage of A. baumannii 17978
was inoculated in Mueller Broth (MH) medium with increasing concentrations of colistin for 12 days. The final strains were sent for whole genome sequencing. The
mutations were detected by breseq, which mapped the sequenced reads onto the reference genome. The mutations related to colistin resistance or fitness are
labeled above the strain.
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FIGURE 2 | Resistance and fitness of the wild type and evolved strains. For the wild type and evolved strains, the relative fitness is shown as a function of the
minimum inhibitory concentration (MIC) for colistin. Each box symbol represents one strain. The relative fitness was determined by measuring the growth rate in MH
medium at OD600. The growth rate was calculated from the OD600 values during exponential growth by an R script. (A–D) Four colonies of A. baumannii strains
evolved in solid agar plates. (E) The strain evolved in liquid media.
(ATCC 17978), the LPS-deficient mutant (A-4-60, XH193), and
the LPS-modified mutant (C-1-12, XH198) in FBS. There was
significant difference in the growth rate of the wild type strain and
LPS-deficient mutants in MH (Figure 4A). However, both the
LPS-deficient mutant and LPS-modified mutant showed higher
inhibition in FBS compared to that of the wild type strain. Both
the LPS-deficient mutant and LPS-modified mutant exhibited a
decrease in their final biomass (Figures 4B,C).
Colistin-Resistant Mutation Alters the
Antibiotic Resistance Profiles
To examine the effect of the LPS mutation on antibiotic
resistance, we determined the MICs of several antibiotics
(including quinolones, aminoglycosides, tetracycline, and
β-lactams). Table 1 shows the MICs of different antibiotics
for A. baumannii ATCC 17978 and its colistin mutants.
Overall, the changes in the MIC trends could be divided
into two groups. The first group included seven strains that
showed increased sensitivity to several types of antibiotics
except colistin. All seven strains harbored mutations that
disrupted the LPS biosynthesis pathway, leading to LPS
loss. The second group contained only one strain: C-1-
12 (XH198). This strain was resistant to all antibiotics
except ampicillin and imipenem, and its colistin resistance
mechanism involved an LPS modification. Thus, the LPS
mutations resulted in differences in the antibiotic resistance
profiles.
DISCUSSION
In this study, we investigated the evolutionary pathway of
A. baumannii that led to colistin resistance. Mutations in pmrB,
lpxC, lpxA, and lpxD were detected early in the selection process.
These results confirmed the findings of previous reports (Adams
et al., 2009; Moffatt et al., 2010; Olaitan et al., 2014). In
addition, four putative proteins, A1S_1983, hepA, A1S_3026,
and rsfS were proposed to be involved in colistin resistance
in this study. A1S_1983 is a putative exported protein. The
ATP-dependent helicase HepA (A1S_2462) is a transcriptional
regulator that activates transcription under stress conditions.
The HepA mutation resulted in reduced exopolysaccharide
coverage and increased retention of penicillin G compared to
that of the wild type strain in E. coli strain; moreover, the
mutant was more sensitive to norfloxacin, chloramphenicol, and
gentamicin than the wild type (Lynch et al., 2007). A1S_3026
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FIGURE 3 | (A) Coverage of colistin-resistant strains derived from A. baumannii ATCC 17978. Each plot shows the coverage for the alignment of each strain to the
ATCC 17978 reference strain. The mean coverage for each strain is denoted by a curve (blue). Duplicated genomic segments appear as regions showing two or
more mean coverages. (B) Confirmation of the 100 kb duplication in the colistin-resistant strains by RT-PCR. The genomic DNA was obtained from the strains and
used as templates for RT-PCR. Three RT-PCR primers were designed upstream (up, A1S_3272), in the center (A1S_3302), and downstream (down, A1S_3366) of
the duplication fragment. The error bars represent the SE from three replicates.
is a ribonuclease T2 family protein, and a mutation in this
gene limits A. baumannii’s ability to colonize inanimate surfaces
and bacterial mobility (Jacobs et al., 2014). RsfS (A1S_0570) is
a ribosomal silencing factor that helps bacteria adapt to slow
growth conditions (Hauser et al., 2012). The first protein is a
membrane protein; its mutation would influence the integrity of
the membrane, possibly leading to colistin resistance. The latter
three proteins affected exopolysaccharide production, biofilm
formation and bacterial adaptation, indicating new colistin
resistance mechanisms. Recently, six genes (vacJ, pldA, ttg2C,
pheS, and conserved hypothetical protein) were shown to have
a role in colistin resistance (Thi Khanh Nhu et al., 2016). We also
identified mutation in vacJ, but did not link the vacJ mutation to
colistin resistance. This may be due to different mutations in vacJ
in Nhu’s and our study. Moreover, these result also demonstrated
the diversity of novel colistin resistance mechanism.
The LPS loss mutant showed a high fitness cost, which limited
its spread in clinical environments. We identified two fitness
compensatory mutations: A1S_3026 and RsfS in this study. These
fitness compensatory mutations increase the fitness of the LPS
loss mutant and promote its survival and spread in the clinical
environment. However, we confirmed that the LPS-deficient
mutants possessed an altered antibiotic resistance profile that was
not observed in the LPS modification mutants. Colistin resistance
in A. baumannii leads to changes in the antibiotic resistance
profile (Moffatt et al., 2010; Lopez-Rojas et al., 2011b; Wand
et al., 2015). The change in the antibiotic resistance profiles of the
LPS-deficient mutants was caused by the increased permeability
of the outer membrane to antibiotics (Moffatt et al., 2010).
LPS in the outer membrane of A. baumannii acts as a highly
selective permeability barrier (Nikaido, 2003). LPS loss removed
the selective permeability of the barrier for antibiotics, whereas
the LPS modification resulted in only minor changes in the
permeability of the A. baumannii outer membrane. The pmrB
mutant presented little or no change in susceptibility to these
antibiotics (Wand et al., 2015). In this study, the pmrB mutant
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FIGURE 4 | (A) The growth rate of the wild type strain (ATCC 17978), the LPS (Lipopolysaccharide)-deficient mutant (A-4-60, XH193) and the LPS-modified mutant
(C-1-12, XH198) in MH and fetal bovine serum (FBS). The wild type strain (ATCC 17978), LPS-deficient mutant (A-4-60, XH193), and LPS-modified mutant (C-1-12,
XH198) were grown in MH and FBS at 37◦C. The growth rates of the strains were determined by measuring the OD600 every 5 min and were estimated by an R
script based on the OD600 curves. Each strain represents four biological and four technical replicates. The growth curves of the wild type strain (ATCC 17978),
LPS-deficient mutant (A-4-60, XH193), and LPS-modified mutant (C-1-12, XH198) in MH (B) and FBS (C).
TABLE 1 | Antimicrobial susceptibilities of Acinetobacter baumannii ATCC 17978 and its colistin mutants.
Minimum inhibitory concentration (MIC; mg/L)a
Strain Lineage CI GM AK MC TGC AM MP IP
17978 0.25 0.75 2 0.75 0.38 48 0.38 0.38
XH191 A-1-60 0.125 0.38 0.5 <0.016 0.032 3 0.016 0.094
XH181 B-1-60 0.094 0.25 0.5 <0.016 0.047 2 0.012 0.125
XH192 A-2-60 0.25 1 0.5 0.016 <0.016 1 0.016 <0.002
XH182 B-2-60 0.125 0.094 0.19 0.032 0.064 1 0.008 0.064
XH183 B-3-60 0.094 0.38 0.5 0.032 0.032 3 0.016 0.125
XH193 A-4-60 0.094 0.5 1 0.016 0.094 3 0.032 0.125
XH184 B-4-60 0.125 0.19 0.5 0.032 0.064 1.5 0.008 0.064
XH198 C-1-12 1 2 8 1 3 12 0.5 0.25
aCI, ciprofloxacin; GM, gentamicin; AK, amikacin; MC, minocycline; TGC, tigecycline; AM, ampicillin; MP, meropenem; IP, imipenem.
showed increased resistance to antibiotics. This may be due to
changes in the permeability of the outer membrane by the pmrB
mutation.
Previous studies have also demonstrated that the pmrB
mutation resulted in no or a slight fitness cost (Durante-
Mangoni et al., 2015; Wand et al., 2015). Our result
confirmed these findings. These results explained why the
LPS modification only resulted in a small change in the
bacteria compared to the LPS loss. However, we did not
determine the effect of colistin resistance-related mutations
on the virulence of A. baumannii isolates in vivo. Colistin
resistance was previously associated with lower in vivo fitness
and reduced virulence in A. baumannii (Lopez-Rojas et al.,
2011a).
In our study, LPS loss affected the growth rate of A. baumannii
in nutrient-rich medium and serum. The loss of the O-ag
capsule in Salmonella typhimurium was also reported to reduce
the resistance to serum but did not affect the growth rate
(Marshall and Gunn, 2015). The LPS loss was not shown to
contribute to serum resistance in A. baumannii (Moffatt et al.,
2013). However, our results did not support that conclusion.
LPS modification decreased the growth rate of A. baumannii
in serum and in nutrient-rich medium. The LPS modified
mutation also contributed to serum resistance in A. baumannii.
The conflict between Moffatt and our results may be caused
by the different genetic backgrounds of ATCC 19606 used
in Moffatt’s study and ATCC 17978 used in our study. Both
of the LPS mutants showed a decreased the final biomass,
whereas serum resistance was normal following incubation in
serum for 30 min (Moffatt et al., 2013). The decreased biomass
indicated that the serum resistance assay required further
improvements.
Overall, colistin resistance A. baumannii rapidly developed.
We not only confirmed the existence of a previously reported
colistin resistance mechanism, but also identified four
novel putative proteins involved in colistin resistance. The
compensatory mutations partially or completely recovered the
LPS-deficient mutant’s fitness, suggesting that compensatory
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mutations played an important role in the emergence and spread
of colistin resistant A. baumannii.
Nucleotide Sequence Accession
Numbers
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